Literature DB >> 16253791

Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.

Eva Tejerina1, Fernando Frutos-Vivar, Marcos I Restrepo, Antonio Anzueto, Fernando Palizas, Marco González, Carlos Apezteguía, Fekri Abroug, Dimitros Matamis, Guillermo Bugedo, Andrés Esteban.   

Abstract

PURPOSE: To evaluate the variables associated with mortality of patients with community-acquired pneumonia who require mechanical ventilation and to determine the attributable morbidity and intensive care unit (ICU) mortality of community-acquired pneumonia.
MATERIAL AND METHODS: Retrospective cohort study carried out in 361 ICUs from 20 countries including 124 patients who required mechanical ventilation on the first day of admission to the hospital due to acute respiratory failure secondary to severe community-acquired pneumonia. To assess the factors associated with outcome, a forward stepwise logistic regression analysis was performed, and to determine the attributable mortality of community-acquired pneumonia, a matched study design was used.
RESULTS: We found 3 independent variables significantly associated with death in patients with community-acquired pneumonia requiring mechanical ventilation: simplified acute physiological score greater than 45 (odds ratio, 5.5 [95% confidence interval, 1.7-12.3]), shock (odds ratio, 5.7 [95% confidence interval, 1.7-10.1]), and acute renal failure (odds ratio, 3.0 [95% confidence interval, 1.1-4.0]). There was no statistically significant difference in ICU mortality among patients with or without community-acquired pneumonia (32% vs 35%; P=.59).
CONCLUSIONS: Community-acquired pneumonia needing mechanical ventilation is not a disease associated with higher mortality. The main determinants of patient outcome were initial severity of illness and the development of shock and/or acute renal failure.

Entities:  

Mesh:

Year:  2005        PMID: 16253791     DOI: 10.1016/j.jcrc.2005.05.010

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  9 in total

1.  Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.

Authors:  Dennis Chen; Marcos I Restrepo; Michael J Fine; Mary Jo V Pugh; Antonio Anzueto; Mark L Metersky; Brandy Nakashima; Chester Good; Eric M Mortensen
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

2.  Infections of respiratory or abdominal origin in ICU patients: what are the differences?

Authors:  Elena Volakli; Claudia Spies; Argyris Michalopoulos; A B Johan Groeneveld; Yasser Sakr; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

3.  4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumonia.

Authors:  Anil Sapru; Helen Hansen; Temitayo Ajayi; Ron Brown; Oscar Garcia; HanJing Zhuo; Joseph Wiemels; Michael A Matthay; Jeanine Wiener-Kronish
Journal:  Anesthesiology       Date:  2009-05       Impact factor: 7.892

4.  Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy.

Authors:  Ayman M Noreddin; Walid F Elkhatib; Kenji M Cunnion; George G Zhanel
Journal:  Drug Healthc Patient Saf       Date:  2011-10-07

5.  Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study.

Authors:  Pekka Ylipalosaari; Tero I Ala-Kokko; Jouko Laurila; Pasi Ohtonen; Hannu Syrjälä
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

6.  Comparison of clinical characteristics and outcomes between aspiration pneumonia and community-acquired pneumonia in patients with chronic obstructive pulmonary disease.

Authors:  Yasuhiro Yamauchi; Hideo Yasunaga; Hiroki Matsui; Wakae Hasegawa; Taisuke Jo; Kazutaka Takami; Kiyohide Fushimi; Takahide Nagase
Journal:  BMC Pulm Med       Date:  2015-07-08       Impact factor: 3.317

7.  Risk factors for mortality in patients admitted to intensive care units with pneumonia.

Authors:  Guowei Li; Deborah J Cook; Lehana Thabane; Jan O Friedrich; Tim M Crozier; John Muscedere; John Granton; Sangeeta Mehta; Steven C Reynolds; Renato D Lopes; Francois Lauzier; Andreas P Freitag; Mitchell A H Levine
Journal:  Respir Res       Date:  2016-07-11

8.  Clinical manifestations of pneumonia according to the causative organism in patients in the intensive care unit.

Authors:  Jung-Kyu Lee; Jinwoo Lee; Young Sik Park; Chang Hoon Lee; Jae-Joon Yim; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Sang-Min Lee
Journal:  Korean J Intern Med       Date:  2015-10-30       Impact factor: 2.884

9.  Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients.

Authors:  Miquel Ferrer; Chiara Travierso; Catia Cilloniz; Albert Gabarrus; Otavio T Ranzani; Eva Polverino; Adamantia Liapikou; Francesco Blasi; Antoni Torres
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.